Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Mar 27, 16:00
Sinovac Biotech Cash and Short Term Investments (Quarterly): 11.07B for June 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 11.07B |
December 31, 2022 | 11.31B |
June 30, 2022 | 11.85B |
December 31, 2021 | 13.42B |
June 30, 2021 | 9.817B |
December 31, 2020 | 1.176B |
September 30, 2020 | 184.11M |
June 30, 2020 | 176.72M |
March 31, 2020 | 186.53M |
December 31, 2019 | 202.99M |
September 30, 2019 | 176.28M |
June 30, 2019 | 170.63M |
March 31, 2019 | 168.42M |
December 31, 2018 | 177.08M |
June 30, 2018 | 88.11M |
December 31, 2017 | 114.42M |
June 30, 2017 | 54.98M |
December 31, 2016 | 62.43M |
September 30, 2016 | 54.32M |
June 30, 2016 | 49.22M |
March 31, 2016 | 62.51M |
December 31, 2015 | 63.83M |
September 30, 2015 | 54.36M |
June 30, 2015 | 64.76M |
March 31, 2015 | 63.07M |
Date | Value |
---|---|
December 31, 2014 | 91.29M |
September 30, 2014 | 94.35M |
June 30, 2014 | 89.63M |
March 31, 2014 | 101.65M |
December 31, 2013 | 107.24M |
September 30, 2013 | 89.03M |
June 30, 2013 | 92.05M |
March 31, 2013 | 91.56M |
December 31, 2012 | 91.24M |
September 30, 2012 | 81.96M |
June 30, 2012 | 89.44M |
March 31, 2012 | 94.49M |
December 31, 2011 | 104.29M |
September 30, 2011 | 94.20M |
June 30, 2011 | 92.72M |
March 31, 2011 | 92.50M |
December 31, 2010 | 103.10M |
September 30, 2010 | 92.42M |
June 30, 2010 | 104.63M |
March 31, 2010 | 127.27M |
December 31, 2009 | 82.27M |
September 30, 2009 | 46.58M |
June 30, 2009 | 46.70M |
March 31, 2009 | 23.31M |
December 31, 2008 | 32.89M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
168.42M
Minimum
Mar 2019
13.42B
Maximum
Dec 2021
4.608B
Average
202.99M
Median
Dec 2019
Cash and Short Term Investments (Quarterly) Benchmarks
Zai Lab Ltd | 806.45M |
I-MAB | 406.06M |
Gracell Biotechnologies Inc (DELISTED) | 234.08M |
Adagene Inc | 128.76M |
YS Biopharma Co Ltd | 35.62M |